Vaccine component BNT162b4 enhances T-cell immunity against SARS-CoV-2 variants for reduced COVID-19 disease severity
Researchers designed a novel messenger ribonucleic acid (mRNA) vaccine component designated BNT162b4.
Stay updated with breaking news from Cell Journal. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Researchers designed a novel messenger ribonucleic acid (mRNA) vaccine component designated BNT162b4.
Researchers at the Francis Crick Institute and King’s College London have created a tool to predict the effects of different diets on both cancerous cells and
People with diabetes who experience periods of low blood sugar — a common occurrence in those new to blood sugar management — are more likely to have worsen
A leading laboratory in photonics and renewable energy at the University of Ottawa has developed a new method for measuring the solar energy produced by bifacia
A newly published study from York University sheds light on the biological underpinnings in sex differences in obesity-related disease, with researchers observi